The expression of μ-opioid receptors in the developing rat spinal cord (Postnatal days 7, 14, 30) was studied by autoradiography using [3H]DAMGO. When compared to camera lucida drawings, the receptor was noted over the entire gray matter and dorsal root ganglia at postnatal days 7 and 14. At postnatal day 30, the receptor expression decreased over the gray matter except the superficial laminae (laminae I and II). At all age groups studied, a higher expression of the receptor was noted over the superficial laminae. The study shows that μ-opioid receptors appears early in postnatal development and attains mature receptor distribution relatively late in ontogeny, suggesting a possible role in the normal development of nervous system. This is a...
<p>Opioid receptors: <i>zfmor</i> (A, C and E), <i>zfdor1</i> (G, I and K) an<i>d zfdor2</i> (M, O a...
Clinical and experimental data suggests that noxious stimulation at critical stages of development r...
Opioids are increasingly used in infants to treat postoperative pain, despite our lack of knowledge ...
AbstractSignificant opioid-dependent changes occur during the fourth postnatal week in supraspinal s...
Significant opioid-dependent changes occur during the fourth postnatal week in supraspinal sites (ro...
The distribution of mu opioid receptors was studied in human fetal spinal cords between 12-13 and 24...
The physiology and function of nociceptive and opioid signalling pathways undergo substantial postna...
Few satisfactory protocols exist for primary culture of postnatal brainstem neurons, and commonly us...
We investigated the postnatal ontogeny of opioid receptors in rat brain under assay conditions which...
The ontogenetic pattern of multiple opioid binding sites in rat brain from birth until weaning has b...
Saturation binding studies with the κ1-selective agonists [3H]U-69,593 and [3H]CI-977 have been used...
AbstractAlthough a large superfamily of G-protein-coupled receptors serves multiple functions, littl...
Significant opioid- and endocannabinoid-dependent changes occur within the periaqueductal grey (PAG)...
Buprenorphine, a mu opioid receptor partial agonist and kappa opioid receptor (KOR) antagonist, is a...
Treatment with buprenorphine represents a promising alternative for pregnant opioid addicts but ther...
<p>Opioid receptors: <i>zfmor</i> (A, C and E), <i>zfdor1</i> (G, I and K) an<i>d zfdor2</i> (M, O a...
Clinical and experimental data suggests that noxious stimulation at critical stages of development r...
Opioids are increasingly used in infants to treat postoperative pain, despite our lack of knowledge ...
AbstractSignificant opioid-dependent changes occur during the fourth postnatal week in supraspinal s...
Significant opioid-dependent changes occur during the fourth postnatal week in supraspinal sites (ro...
The distribution of mu opioid receptors was studied in human fetal spinal cords between 12-13 and 24...
The physiology and function of nociceptive and opioid signalling pathways undergo substantial postna...
Few satisfactory protocols exist for primary culture of postnatal brainstem neurons, and commonly us...
We investigated the postnatal ontogeny of opioid receptors in rat brain under assay conditions which...
The ontogenetic pattern of multiple opioid binding sites in rat brain from birth until weaning has b...
Saturation binding studies with the κ1-selective agonists [3H]U-69,593 and [3H]CI-977 have been used...
AbstractAlthough a large superfamily of G-protein-coupled receptors serves multiple functions, littl...
Significant opioid- and endocannabinoid-dependent changes occur within the periaqueductal grey (PAG)...
Buprenorphine, a mu opioid receptor partial agonist and kappa opioid receptor (KOR) antagonist, is a...
Treatment with buprenorphine represents a promising alternative for pregnant opioid addicts but ther...
<p>Opioid receptors: <i>zfmor</i> (A, C and E), <i>zfdor1</i> (G, I and K) an<i>d zfdor2</i> (M, O a...
Clinical and experimental data suggests that noxious stimulation at critical stages of development r...
Opioids are increasingly used in infants to treat postoperative pain, despite our lack of knowledge ...